These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3837048)

  • 1. Septic shock (Part 1).
    Berringer R; Harwood-Nuss AL
    J Emerg Med; 1985; 3(6):475-83. PubMed ID: 3837048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock.
    Ball HA; Cook JA; Wise WC; Halushka PV
    Intensive Care Med; 1986; 12(3):116-26. PubMed ID: 3016060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-endorphin-like-immunoreactivity levels and hemodynamics in patients with septic shock.
    Hughes GS
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):121-31. PubMed ID: 3158042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist.
    Gahhos FN; Chiu RC; Hinchey EJ; Richards GK
    Arch Surg; 1982 Aug; 117(8):1053-7. PubMed ID: 6285853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of targets and mediators in endotoxin shock.
    Kováts TG
    Adv Exp Med Biol; 1971 Oct; 23(0):347-63. PubMed ID: 4137296
    [No Abstract]   [Full Text] [Related]  

  • 7. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.
    Rank N; Michel C; Haertel C; Lenhart A; Welte M; Meier-Hellmann A; Spies C
    Crit Care Med; 2000 Dec; 28(12):3799-807. PubMed ID: 11153617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone therapy on hemodynamics and metabolism following a superlethal dosage of Escherichia coli endotoxin in dogs.
    Raymond RM; Harkema JM; Stoffs WV; Emerson TE
    Surg Gynecol Obstet; 1981 Feb; 152(2):159-62. PubMed ID: 6782687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.
    Danner RL; Natanson C; Elin RJ; Hosseini JM; Banks S; MacVittie TJ; Parrillo JE
    Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of physiologic patterns in surgical septic shock.
    Shoemaker WC; Appel PL; Kram HB; Bishop MH; Abraham E
    Crit Care Med; 1993 Dec; 21(12):1876-89. PubMed ID: 8252893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.
    Parratt JR; Sharma N; Zeitlin IJ
    Br J Pharmacol; 1984 May; 82(1):281-8. PubMed ID: 6428499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone on hemodynamics, oxygen transport, and metabolic variables in canine endotoxin shock.
    Thijs LG; Balk E; Tuynman HA; Koopman PA; Bezemer PD; Mulder GH
    Circ Shock; 1983; 10(2):147-60. PubMed ID: 6839424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamics of human septic shock relate to circulating innate immunity factors.
    Hartemink KJ; Groeneveld AB
    Immunol Invest; 2010; 39(8):849-62. PubMed ID: 20718660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septic shock (endotoxic shock).
    Cavanagh D; Rao PS
    Clin Obstet Gynecol; 1973 Jun; 16(2):25-39. PubMed ID: 4197324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympathomedullary involvement.
    Holaday JW; D'Amato RJ; Ruvio BA; Feuerstein G; Faden AI
    Circ Shock; 1983; 11(3):201-10. PubMed ID: 6317225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and metabolic correlations in human sepsis. Invited commentary.
    Siegel JH; Cerra FB; Coleman B; Giovannini I; Shetye M; Border JR; McMenamy RH
    Surgery; 1979 Aug; 86(2):163-93. PubMed ID: 380033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy and oxygen metabolism disorder during septic acute kidney injury.
    Yang RL; Wang XT; Liu DW; Liu SB
    Kidney Blood Press Res; 2014; 39(4):240-51. PubMed ID: 25171106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and treatment of septic shock.
    Rackow EC; Astiz ME
    JAMA; 1991 Jul 24-31; 266(4):548-54. PubMed ID: 2061983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.
    Faden AI; Holaday JW
    J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endorphins and vasopressin in canine endotoxin shock.
    Cronenwett JL; Baver-Neff BS; Grekin RJ; Sheagren JN
    J Surg Res; 1986 Dec; 41(6):609-19. PubMed ID: 2946895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.